BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6205290)

  • 1. [Pyrimidine nucleoside phosphorylase in brain tumors and anti-tumor effect of 5'-DFUR].
    Shibui S
    Neurol Med Chir (Tokyo); 1984 Feb; 24(2):65-72. PubMed ID: 6205290
    [No Abstract]   [Full Text] [Related]  

  • 2. [Activities of pyrimidine nucleoside phosphorylase in brain tumors and antitumor effect of 5'-DFUR].
    Shibui S; Watanabe T; Miki Y; Nomura K; Miwa M
    No To Shinkei; 1983 Oct; 35(10):1017-22. PubMed ID: 6228241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of 5'-deoxy-5-fluorouridine in human digestive organ cancer xenografts and pyrimidine nucleoside phosphorylase activity in normal and neoplastic tissues from human digestive organs.
    Nio Y; Kimura H; Tsubono M; Tseng CC; Kawabata K; Masai Y; Hayashi H; Meyer C; Fukumoto M; Tobe T
    Anticancer Res; 1992; 12(4):1141-6. PubMed ID: 1386969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The study of 5-FU levels and pyrimidine nucleoside phosphorylase (PyNPase) activity in human breast cancer tissue after administration of 5'-deoxy-5-fluorouridine (5'-DFUR)].
    Yayoi E; Takatsuka Y; Miyauchi K; Hirai T; Aikawa T; Maeura Y; Kaji M; Kitada M; Kotsuma Y; Satomi T
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1371-4. PubMed ID: 2142401
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of 5'-deoxy-5-fluorouridine (5'-DFUR) on the activity of pyrimidine nucleoside phosphorylase (pyNPase) in normal and tumor tissues of human stomach].
    Kimura T; Kobayashi T; Nakaya Y; Iida T; Uchimura M; Murohisa B; Nagashima T; Matsumoto Y; Kitamura H; Shibata M
    Gan To Kagaku Ryoho; 1995 Jul; 22(8):1051-6. PubMed ID: 7611757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Conversion of 5'-deoxy-5-fluorouridine to 5-FU by pyrimidine nucleoside phosphorylases in normal and tumor tissues from rodents bearing tumors and cancer patients].
    Miwa M; Nishimura J; Kamiyama T; Ishitsuka H
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2924-9. PubMed ID: 2959206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of 5-fluorouracil (5-FU) levels and pyrimidine nucleoside phosphorylase activities in the tissues from patients with uterine cervical and ovarian cancers after oral administration of 5'-DFUR].
    Noda K; Watanabe Y; Ikeda M; Takeuchi K; Hasegawa K; Kinugasa M; Sekiba K; Kobashi Y; Ohiwa T; Odagiri H
    Gan To Kagaku Ryoho; 1991 Dec; 18(15):2551-5. PubMed ID: 1836128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of intratumor administration of OK-432 on the tumor selectivity of 5'-DFUR].
    Ogawa K; Katsube T; Konno S; Miura K; Wakasugi S; Watanabe T; Shimakawa T; Ishikawa S; Naritaka Y; Yagawa H
    Gan To Kagaku Ryoho; 1995 Dec; 22(14):2095-100. PubMed ID: 8607621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of intestinal pyrimidine nucleoside phosphorylases.
    Wientjes MG; Au JL
    Pharm Res; 1987 Oct; 4(5):425-8. PubMed ID: 2977647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of pyrimidine nucleoside phosphorylase enhances the sensitivity to 5'-deoxy-5-fluorouridine in tumour cells in vitro and in vivo.
    Nagata T; Nakamori M; Iwahashi M; Yamaue H
    Eur J Cancer; 2002 Mar; 38(5):712-7. PubMed ID: 11916555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of orally administered 5-fluorouracil and its derivative 5'-deoxy-5-fluorouridine on 7,12-dimethylbenz[a]anthracene-induced breast carcinomas in rats.
    Sawada Y; Ohno T; Shimoyama T; Uematsu K; Odagiri H
    J Int Med Res; 1991; 19(3):249-70. PubMed ID: 1834492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of preoperative oral 5'-DFUR on PyNPase level in gastrointestinal malignant tumor tissues].
    Wang WJ; Shi D; Wang SM
    Ai Zheng; 2003 Jun; 22(6):653-7. PubMed ID: 12948420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antitumor effect of 5'-DFUR and PyNPase activity in colorectal cancer].
    Honda M; Tanaka Y; Matsuo Y; Yamamoto S; Hazama K; Inoue Y; Takao T; Fushimi H
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):939-43. PubMed ID: 10396321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced therapeutic efficacy of 5'deoxy-5-fluorouridine in 5-fluorouracil resistant head and neck tumours in relation to 5-fluorouracil metabolising enzymes.
    Peters GJ; Braakhuis BJ; de Bruijn EA; Laurensse EJ; van Walsum M; Pinedo HM
    Br J Cancer; 1989 Mar; 59(3):327-34. PubMed ID: 2522792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [5'-Deoxy-5-fluorouridine enzymatic activation from the masked compound to 5-fluorouracil in human malignant tissues].
    Hara Y
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2133-43. PubMed ID: 6237613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrimidine nucleoside phosphorylase and dihydropyrimidine dihydrogenase activities as predictive factors for the efficacy of doxifluridine together with mitomycin C as adjuvant chemotherapy in primary colorectal cancer.
    Nishioka M; Miyamoto H; Kurita N; Higashijima J; Yoshikawa K; Miyatani T; Shimada M
    Hepatogastroenterology; 2007 Jun; 54(76):1089-93. PubMed ID: 17629045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal treatment regimens for 5'-deoxy-5-fluorouridine, with or without (E)-5-(2-bromovinyl)-2'-deoxyuridine, against various tumors in mice.
    Iigo M; Miwa M; De Clercq E
    Jpn J Cancer Res; 1990 Apr; 81(4):431-5. PubMed ID: 2142152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation between pyrimidine nucleoside phosphorylase (PyNPase)/thymidine phosphorylase/platelet-derived endothelial cell growth factor and histological prognostic factor, and influence of 5'-deoxy-5-fluorouridine (5'-DFUR) administration on PyNPase activities and serum immunosuppressive acidic protein levels. A study group of oral anti-cancer drugs in Seiban/Tajima area].
    Satoh B; Ohtoshi M; Ishida Y; Hen-mi K; Kaneko I; Soda M; Sugihara J; Shibagaki F; Iwai N; Nakamura T; Yamasaki T; Matsumoto S
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):359-64. PubMed ID: 9492829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor specific conversion of a pyrimidine antimetabolite.
    Hartmann HR; Bollag W
    Adv Exp Med Biol; 1984; 165 Pt B():411-4. PubMed ID: 6232832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of acyclothymidine, a potent pyrimidine nucleoside phosphorylase inhibitor, on the pharmacokinetics of doxifluridine in rabbits via oral administration.
    Hamada A; Fukushima S; Morinaga A; Saneyoshi M; Kawaguchi T; Nakano M
    Biol Pharm Bull; 1993 Dec; 16(12):1297-300. PubMed ID: 8130783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.